Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Sivextro

Sivextro 245 mg powder for oral suspension · Abschnitt 4.8 · PDF-Seite 36–37

HOS-130302 · Präparat HOS-096879

36  System organ class Frequency Adverse reactions Cardiac disorders Uncommon: Bradycardia Vascular disorders Uncommon: Flushing, hot flush Respiratory, thoracic and Uncommon: Cough, nasal dryness, pulmonary congestion mediastinal disorders Gastrointestinal disorders Common: Nausea, diarrhoea, vomiting Uncommon: Abdominal pain, constipation, abdominal discomfort, dry mouth, dyspepsia, abdominal pain upper, flatulence, gastro-oesophageal reflux disease, haematochezia, retching Skin and subcutaneous tissue Common: Pruritus generalised disorders Uncommon: Hyperhidrosis, pruritus, rash, urticaria, alopecia, rash erythematous, rash generalised, acne, pruritus allergic, rash maculo-papular, rash papular, rash pruritic Musculoskeletal and Uncommon: Arthralgia, muscle spasms, back pain, limb connective tissue disorders discomfort, neck pain Renal and urinary disorders Uncommon: Urine odour abnormal Reproductive system and Uncommon: Vulvovaginal pruritus breast disorders General disorders and Common: Fatigue administration site conditions Uncommon: Chills, irritability, pyrexia, peripheral oedema Investigations Uncommon: Grip strength decreased, transaminases increased, white blood cell count decreased * Based on post-marketing reports. Since these reactions are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency which is therefore categorised as not known.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.